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ABSTRACT
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Rhizoma Drynaria (RD) has been widely used for healing bone fractures or related diseases in traditional Chinese medicine.
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properties in OVX mice, followed by the study of its
effects on rat osteoblast-like UMR 106 cells. It is hope that
the studies would provide evidence to support the use of
Rhizoma Drynaria as alternatives for prevention and
treatment of postmenopausal osteoporosis.

MATERIALS AND METHODS
I. Preparation of Rhizoma Drynaria Total Flavonoid
Extract
Rhizomes of Drynaria fortune were collected in
Guizhow province, China in 2005 and were identified by
Professor Zhou Rong-Han (Chinese Pharmaceutical
University, Nanjing, Jiansu, China). The total flavanoid
fraction of rhizomes of D. fortune (50 kg) were preapared
by extraction with 60% ethanol and chromatographed on a
D-101 macroporous resin column (Φ25 × 150 cm) with
gradients of water and 30, 50 and 95% alcohol. High
performance of liquid chromatography (HPLC) was
performed on a Shimadzu C18 column (Φ250 × 4.6 cm) in
Agilent series 1100 (USA) to analyze the compounds in
the total flavonoid extract of Rhizoma Drynaria.
II. Animal Study
Sixty one-month old female C57/BL6J mice from the
Chinese University of Hong Kong were housed in
environmentally controlled central animal facilities. The
mice were either sham-operated or ovariectomized (OVX)
at the age of one month. After recovering for two weeks,
the mice were randomly selected and divided into 6 groups.
One group was sham vehicle (2% Ethanol), the others
were OVX vehicle; OVX 17β-estradiol (2µg/g/day) and 3
groups of OVX RD total flavonoid (RDTF) extract: Low
dose: 0.087; Medium dose: 0.173; and High dose: 0.347
mg/g/day. Treatments were administrated orally to the 6
groups of animals for 6 weeks. Animals were pair-fed with
diet containing 0.6% Ca and 0.65% P (TD 98005, Teklad,
Madison, WI) and were allowed free access to water
throughout the course of the studies as previously
described(7). The care and treatment protocol was approved
by the Animal Ethics Committee of the Hong Kong
Polytechnic University. Urine samples were collected one
day before sacrifice. Blood samples, uteri and bone
specimens (femur, tibia and lumbar spine) were collected
at the end of the experiment.

mineral densities (BMD), trabecular BMD, total
cross-sectional area, trabecular cross-sectional area and
stress-strain index (SSI) in the distal/proximal were
determined.
IV. Rat Osteoblastic UMR-106 Cell Culture Study
UMR-106 cells (ATCC no. CRL-1661) were cultured
in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS),
penicillin 100 U/mL and streptomycin 100 µg/mL at 37oC
in a humidified atmosphere of 95% air and 5% CO2 as
previously described(7). After 48 h, the medium was
changed to phenol-red free DMEM supplemented with 1%
dextran-charcoal-stripped serum (sFBS) for 24 h. The cells
were then treated with RDTF extract (0.02 to 0.2 µg/mL),
17β-estradiol (10 nM) or vehicle in the presence or
absence of ICI 182, 780 (1 µM) for 48 h before treatment.
Cell proliferation of UMR 106 cells were studied by using
MTS (3-(4,5-dimethylthiazol -2-yl)-5-(3-carboxymethoxyphenyl)
-2-(4-sulfophenyl)-2H tetrazolium) assay (Promega,
#G3580). ALP activity was measured directly on the
monolayer of cell cultures. 100 µL per well of PBS
containing 10 mM p-nitrophenylphosphate (PNP) was
added and shaken for 30 minutes at 37oC. The absorbance
of colour change was measured at 405nm in a microplate
reader. To normalize the result, Bradford protein assay was
carried out and ALP activity was expressed in a unit of
U/L/µg protein.
V. Transient Transfection and Estrogen Receptors (ER)
Mediated Luciferase Activity Assay
The cells were transfected by LipofectamineTM 2000
reagent as previously described(9). ER-α, ER-β and
ERE-containing luciferase reporter plasmid vERETkluc
were kindly provided by Dr. Vincent Giguere (McGill
University, Montreal, Quebec, Canada). After 6 hours of
transfection, the cells were treated with vehicle,
17β-estradiol (10 nM) or RDTF extract (0.2 µg/mL) for
24 h. Cells were then lysed with passive lysis buffer and
luciferase activity was measured using Dual Luciferase
Reporter Assay System (Promega Corporation, Madison,
MI, USA) and the signal was detected by TD-20/20
Luminometer (Turner Design, Sunnyvale, CA, USA). The
estrogen promoter activity was expressed as Firefly
luciferase values normalized by pRL-TK Renilla luciferase
values.

III. Assessment ofBone Propertiesby Peripheral Quantitative Computed Tomography (pQCT)

VI. Immunoblotting

Trabecular and cortical bone densities of left femur,
tibia and lumbar spine region L1 were measured using
StraTec
XCT2000
machine
(Norland
Stratec
Medizintechnik, GmbH, Birkenfeld, Germany). Mid-shaft
and distal regions of femur and tibia were scanned. All
scans were performed using the developed protocol
designed for studying isolated small bones(8). Total bone

Treated cells were harvested and lysed with passive
lysis buffer (Promega, Madison, MI, USA) as previously
described(9). Protein concentrations were determined using
Bradford assay. Equal amounts of proteins were separated
by SDS-PAGE on a 10 % reducing gel at a constant
voltage (200 V) for about an hour, and transblotted onto
polyvinylidene
fluoride
fluoropolymer
(PVDF)
membranes (Immobilin-P, Millipore Corp., Ma, USA). The
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blots were probed with monoclonal rabbit anti-human
phosphor-ER-α at serine 118 residues (1 : 2000) or
anti-human ER-α (1 : 3000), and followed by incubation
with goat anti-rabbit conjugated with horseradish
peroxidase (1 : 2000). The antigen-antibody complexes
were then detected with enhanced chemiluminescence
(ECL) reagent and visualized by the Lumi-Imager using
Lumi-Analyst version 3.10 software (Roche, Mannheim,
Germany).
VII. Statistical Analysis
The in vivo data were analyzed one-way ANOVA
followed by Tukey’s post test and the in vitro data were
analyzed by the non-paired student’s t-test between control
group and each treatment group using Graphpad PRISM®
software package. Results were expressed as Mean ± SEM
(standard error mean). p-values < 0.05 were considered as
significant.

al.(11) also reported another publication about the chronic
toxicology test. The experimental mice, which they were
fed by RDTF in 60, 80 and 540-fold higher than normal,
did not have obvious side-effect. After all, RDTF is
regarded as safe to consume in terms of both short and
prolong time frame.
Our study showed that RDTF mimicked estrogen in
stimulating cell proliferation and ALP activity via estrogen
receptor (ER) in UMR 106 cells. As shown in Figure 2A
and Figure 2B, RDTF at both 0.02 and 0.2 mg/mL
increased osteoblastic cell proliferation as well as alkaline
phosphatase activities (osteoblastic differentiation) in
UMR 106 cells, and the increase were abolished in the
presence of ICI 182, 780, a specific estrogen receptor
antagonist. These results suggest that the stimulatory
effects of RDTF on osteoblastic fucntions in UMR 106
cells were estrogen receptor dependent. The results were in
agreement with those reported by others(12, 13).
A.

The present study evaluated the osteoprotective
effects and mechanism of actions of the total flavonoid
fraction of Rhizoma Drynariae in ovariectomized mice and
in rat osteoblast-like UMR 106 cells. Our results clearly
demonstrated that RDTF could suppress OVX-induced
loss in bone mass in OVX mice. In particular, treatment of
OVX mice with RDTF at 0.087, 0.173 or 0.346 mg/g/day
significantly increased total BMD and trabecular BMD at
both distal femur and proximal tibia. The increase was
most significant with RDTF at 0.173 mg/g/day (medium
dose) at distal femur as shown in Table 1.
Table 1. Effects of RD Total flavonoid extract on Total Bone Mineral
Density of distal femur and proximal tibia in Sham and OVX mice.
Total BMD (mg/cm)
Distal Femur
a

Proximal Tibia
240.9 + 5.9 a

OVX (Veh)

335.2 + 6.5

E2

453.4 + 8.5 c

325.5 + 12.7 c

RD TF (Low)

377.4 + 4.5 b

267.9 + 5.4 b

RD TF (Med)

395.6 + 4.8 b

300.0 + 4.1 b

RD TF (High)

394.3 + 7.2 b

270.9 + 11.9 b

Sham (Veh)

394.3 + 7.2

b

283.7 + 9.8 b

Results were analyzed by one-way ANOVA and expressed as mean +
SEM (n = 8) a p < 0.05 vs OVX (Veh), b p < 0.05 vs Sham Veh), c p <
0.05 vs OVX (Veh) and Sham (Veh).

According to the normal daily uptake of flavonoids in
human (9 mg/kg/day), our dosages used was about 10, 20
and 40-fold higher than normal. Some studies in China
talked about the acute and chronic effect of administrating
RDTF in mice. Zhao et al.(10) found the LD50 was 66-fold
higher from normal daily human uptake of total flavonoids
in mice. Our dosages were regarded as safe to eat. Zhao et
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Figure 2. The effect of Rhizoma Drynaria total flavonoids on
UMR106 a) cell proliferation and b) cell differentiation in the pres
ence and absence of estrogen antagonists. ^^^ p < 0.001 vs C, ** and
*** p < 0.01 and p < 0.001 vs corresponding dosage without blocker
treatment.

Jeong et al.(12) demonstrated that crude extract of RD was
shown to promote osteoblast differentiation and
mineralization in pre-osteoblastic MC3T3-E1 cells through
regulation of bone morphogenetic protein-2. Similarly,
Zhang et al.(13) showed that serum from RDTF treated rats
significantly promoted proliferation and differentiation of
cultured osteoblasts extracted from newborn Sprague
Dawley rats in a time dependent manner.
To determine if RDTF could activate estrogen
receptor and activate estrogen response element (ERE)-
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dependent transcription, UMR 106 cells were transfected
with ERE-luciferase construct and co-transfected with
plasmids that encode for either ER or ER. As shown in
Figure 3, RDTF at 0.2 g/mL but not 0.02 g/mL
significantly induced ERE-dependent luciferase activities
via ER in UMR 106 cells.
Dual luciferase assay
3.5

ER-alpha
ER-beta

^^

3.0
2.5

*

2.0

^^

Figure 4. The effect of Rhizoma Drynaria total flavonoids on
the expression of phosphorylation of ER-α in UMR106 cells.

1.5
1.0
0.5
0.0

C

E2

RD 0.02

g/mL

Figure 3. The effect of Rhizoma Drynaria total flavonoids on ER-α
and ER-β-mediated ERE-dependent luciferase activity in UMR106
cells. * p < 0.05 vs C (ER-α) ^^ p < 0.01 vs C (ER-β).

Recent studies showed that ER could be activated in
the absence of ligand binding by modulating various signal
transduction pathways such as the mitogen-activated
protein kinase (MAPK) mediated pathways(14-16). Upon
activation of unliganded ERα by MAPK cascade, ERα was
shown to be phosphorylated at serine residue 118 (Ser118),
104 (Ser104) and 167 (Ser167) within the AF-1 domain of
ERα(17). To determine if RDTF activates ER
ligand-independently, the ratio of phosphorylated ERα
(Ser118) to total ERα expression in UMR 106 cells in
response to RDTF treatment was studied. As shown in
Figure 4, 0.2 g/mL RDTF as well as 10-8M E2
significantly induced ER phosphorylation at serine 118 ER
and decreased the expression of ER in UMR 106 cells.
ER phosphorylation at Ser118 was preferentially chosen as
Ser118 is a highly conserved residue that represents the
major site of phosphorylation in response to estradiol(18).
Our results clearly indicated that RDTF at 0.2 g/mL
could activate ER phosphorylation in UMR 106 cells,
suggesting that RDTF could also activate ER
ligand-independently in osteoblastic cells.
The present study clearly demonstrated RDTF is
effective in protecting against ovarietomy-induced bone
loss in mice and exerts direct effects in regulating
osteoblastic cell growth via the activation of ER. Our study
clearly identified the optimal dose of RDTF for achieving
bone protective effects in ovariectomized mice to be 0.173
mg/g/day and demonstrated that RDTF could activate ER
in both ligand dependent as well as ligand-independent
manner. Future studies will be needed to evaluate the
clinical efficacy of RDTF for treatment of osteoporosis in
postmenopausal women.
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